Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component. (Q54050676)

24 May 2018

title

Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component. (English)

1 reference

24 May 2018

1 reference

Kondo Y

1

1 reference

24 May 2018

Koga S

series ordinal

2

1 reference

24 May 2018

Komata T

series ordinal

3

1 reference

24 May 2018

Kondo S

series ordinal

4

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 April 2000

1 reference

24 May 2018

published in

Oncogene

1 reference

24 May 2018

volume

19

1 reference

24 May 2018

issue

18

1 reference

24 May 2018

page(s)

2205-2211

1 reference

24 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203538

exact match

0 references

cites work

Telomere shortening is associated with cell division in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Structure and function of telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Activation of telomerase in a human tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

The RNA component of human telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Telomeres shorten during ageing of human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Telomere reduction in human colorectal carcinoma and with ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Clinical implications of telomerase in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Inhibition of human telomerase activity by peptide nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

21 January 2018

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Inhibition of cell-free protein synthesis by pppA2′ p5′ A2′ p5′ A: a novel oligonucleotide synthesized by interferon-treated L cell extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

7 January 2021

Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

7 January 2021

Telomerase activity in primary prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

7 January 2021

Telomerase activity in human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

7 January 2021

Gene therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203538

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203538

1 reference

24 May 2018

1 reference

24 May 2018